This ETF is trying to satisfy appetites for weight loss stocks
Tema ETFs has been capitalizing on the risk appetite for weight loss stocks. It is behind the GLP-1, Obesity &…
‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News…
Big drug company CEOs to testify at Senate Health committee on insulin prices
The top executives of the three drug companies that control 90% of the global insulin market will testify May 10…
